Abstract

Objectives: To determine the efficacy of intravenous iron administration iniron deficient chronic heart failure patients and to determine the role of brainnatreuretic peptide (BNP) in the diagnosis and monitoring of chronic heartfailure patients.Methodology: The current study was a prospective analytical study. A totalof 96 patients with symptomatic chronic heart failure (CHF) were selectedthrough convenient sampling method. These were divided in to severalgroups based upon findings of echocardiography, 06 minutes' walk test andserum BNP. It was found that 38 patients were iron deficient. Intravenous (I/V)iron sucrose was administered to iron deficient patients weekly for 6 weeksfollowed by reassessment; the compliance rate was 87%.Results: Patients managed with I/V therapy showed significant improvementin all the clinical and biochemical parameters used in the study. New YorkHeart Association class shift was seen in 76% of patients.Conclusions: iron deficient induced CHF is common in our population. Parenteraliron administration (iron sucrose) is an effective modality for managingsuch patients. Serial BNP levels can be used to monitor the response to IViron.